Organ damage proteomic signature identifies patients with MASLD at risk of systemic complications
Our study provides a framework for potential mechanisms associated with systemic diseases that facilitates holistic management by stratifying patients with metabolic dysfunction-associated steatotic liver disease into subclasses at risk of extrahepatic manifestations.
Authors
- Carlos J. Pirola (ORCID: https://orcid.org/0000-0001-8234-4058)
- Tomas Fernández Gianotti (ORCID: https://orcid.org/0000-0003-2569-9156)
- Julio San Martino
- Silvia Sookoian (ORCID: https://orcid.org/0000-0001-5929-5470)
- Martín Garaycoechea
- Luis Diambra (ORCID: https://orcid.org/0000-0001-8052-4880)
- Gustavo Castaño
Institutions
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Universidad Maimónides (AR)
- Hospital Muñiz (AR)
- Hospital El Cruce (AR)
- Universidad Nacional de La Plata (AR)
Publication Details
- Journal
- Hepatology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1097/hep.0000000000001346
- Citations
- 4
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 6.07